SlideShare a Scribd company logo
1 of 25
Download to read offline
a customer and science-focused
contract development & manufacturing organization
HOST CELL PROTEIN ANALYSIS
BY MASS SPECTROMETRY
Michael J Nold, Ph.D.
Director, Mass Spectrometry Core Facility
• Challenges with HCPs
• HCP Spectral Library Generation
• Process Clearance Monitoring
HCP– Analysis by Mass Spectrometry
Overview
2
HCP– Analysis by Mass Spectrometry
Challenges with HCPs
• HCPs are impurities generated when recombinant
proteins are manufactured. Recombinant proteins are
frequently expressed in host cells from various cell
lines.
• Mammalian, Microbial, Bacterial, Yeast, Plant, Insect
• Residual HCPs may affect product quality, safety and
efficacy.
• Toxicity, immune response to target, adjuvant effect, augment
ADA response, bioactivity, product stability, product potency
• Risks from a variety of factors
• Dosing and dose frequency, patient demographics, route of
administration
HCP– Analysis by Mass Spectrometry
Challenges with HCPs
Many Challenges:
• Variability of host cell substrates
• Large number of protein analytes
• Variability of protein population during upstream processing
• Parental cell line, cell age, cell viability, feeding strategy, etc.
• Dynamic range difference between DP and HCPs ( ≥e6 )
• Detection of HCPs that are not immunogenic à Immunoassay
may miss these
• HCP population can change during process development
• HCPs may copurify with DP – “Hitchhiker” effect
HCP– Analysis by Mass Spectrometry
Challenges with HCPs
Mass Spectrometry Challenges:
• Column capacity, sample loading
• DP overload on column
• Mass spectrometer sensitivity
• Dynamic range for ion detections
• False positives, negatives
• Ion statistics for identification, quantitation
• Speed – Data to results to support process development
• Does library reflect the process?
• Time to generate a new library
KBI HCP Reagents and Applications
PHYSICAL
CHEMICAL
ATTRIBUTE #1
PHYSICAL
CHEMICAL
ATTRIBUTE #3
PHYSICAL
CHEMICAL
ATTRIBUTE #2
6
HCP– MS Workflow Overview
LCMS via ACQUITY/6600 TripleTOF
Spectral Library Generation Sample Analysis
Data Processing and Library Searching
Data
Independent
Acquisition
SWATH MS
Data
Dependent
Acquisition
LC-MS/MS
CHO HCCF
Various
Separation
Methodologies
Protein Level
Additional
Separation/
Digest
Peptide
Level
Spectral
Library
1% FDR
Various
Separation
Methodologies
Protein Level
Additional
Separation/
Digest
Peptide
Level
List of
identified
proteins and
peptides
Spectral
library
matching
based on
set search
criteria and
thresholds
Sample
7
HCP– MS Workflow Overview
LCMS via ACQUITY/6600 TripleTOF
Spectral Library Generation Sample Analysis
Data Processing and Library Searching
Data
Independent
Acquisition
SWATH MS
Data
Dependent
Acquisition
LC-MS/MS
CHO HCCF
Various
Separation
Methodologies
Protein Level
Additional
Separation/
Digest
Peptide
Level
Spectral
Library
1% FDR
Various
Separation
Methodologies
Protein Level
Additional
Separation/
Digest
Peptide
Level
List of
identified
proteins and
peptides
Spectral
library
matching
based on
set search
criteria and
thresholds
Sample
7
HCP Spectral Library Generation
Sample Preparation on the Protein and Peptide Level
Process
Samples
1D Analysis - No peptide level fractionation
Process
Samples
2D Analysis - High pH RP-HPLC peptide level fractionation
Fraction 3
Fraction 2
Fraction 1
Fraction 4
Fraction 5
Peptide level fractionation of 5 of
the 8 protein fractionated samples
PHYSICAL
CHEMICAL
ATTRIBUTE #1
PHYSICAL
CHEMICAL
ATTRIBUTE #3
PHYSICAL
CHEMICAL
ATTRIBUTE #2
8
HCP Spectral Library Generation
Sample Load Optimization
• Load Optimization Goal:
achieve a dynamic range of
≥ 3 logs at the protein level for
each experiment.
• Utilize the ITC (ion
transmission control) Count
Conversion of the TOF MS TIC
to determine the appropriate
amount on column: optimized
load when the TOF MS TIC
apex is between 10-20%.
• ITC: dynamically adjusts
percent of the ion beam
(voltage gate) according to an
observed TIC signal to prevent
saturation.
• ITC Count Conversion plots the
ITC voltage gate response:
no signal / gate fully open = 100%
saturation / gate fully closed = 0%
TOF MS TIC – SWATH
ITC Count Conversion of the TOF MS TIC – SWATH
TOF MS TIC Apex
9
1.E+04
1.E+06
1.E+08
0 10 20 30 40 50
ProteinArea
Protein Number
Log Plot of Protein Dynamic Range
HCP Spectral Library Generation
Sample Load Optimization – Depth of Database
• ADH: spiked in all samples at 300 fmol/µL**, used as a system suitability test and
the signal response for relative quantitation.
• PCM: spiked in all samples at 100 fmol/µL**, used as a retention time calibrator
allowing for retention time alignment on any chromatographic system or timescale.
** Concentration of ADH and PCM is relative to 2 µg/µL of total HCP concentration.
XIC - Yeast Alcohol Dehydrogenase (ADH)
XIC - Peptide Calibration Mix (PCM)
Graph generated using the HCPs identified in sample S3 to
conceptually show the dynamic range of identified HCPs.
10
HCP Spectral Library Generation
IDA Library Data Collection and Processing
ProteinPilot™ data processing
w/ Paragon™ Algorithm.
IDA spectral library
Filter IDA spectral library
based on acceptance
criteria.
• Acceptance Criteria for Library:
• 1% FDR
• No modifications or clipped peptides
• Minimum of 2 peptide identifications per
protein
• Peptide Confidence Level: 95%
• 10 ppm mass error tolerance
• 2/2 identification replication
Acquire IDA data in duplicate for
each of 28 HCP samples/fractions.
11
HCP Spectral Library Generation
Contributions from 3 physiochemical preparations & fractionation
Physiochemical
Attribute 1
1850 Proteins
Physiochemical
Attribute 2
2925 Proteins
Physiochemical
Attribute 3
2137 Proteins
3802 Proteins
114
304
1047
598
976
385
378
• HCPs are monitored from samples
collected along a purification process,
either for process development
feedback, or monitoring a final process
for one or more batches.
• Samples are analyzed in triplicate, and
identifications will have to meet a set of
criteria at both peptide and protein
levels.
• Results include the list of identified
HCPs, and relative quantitative
information.
• As an illustration, samples were
obtained from the last four points of
sampling from one of our programs.
Protein A
Viral Inactivation
AEX* Based Polishing
(Flow Through mode)
CEX* Based Polishing
Viral Filtration
UF/DF
Clarified Harvest
*May be mixed mode
S3
S4
S5
S6
HCP Process Clearance Monitoring
Stand Alone, ELISA Support, or Process Development Support
7193 ppm
125 ppm
10 ppm
4 ppm
12
SWATH data file
HCP Ion
Library
Selected
Protein
Selected
Peptide
Acceptance Criteria
• 2 Peptides per protein
• 4 transitions per peptide
• FDR: 1.0%
• Peptide Confidence
Threshold > 99%
• MS/MS ppm: 20.0 ppm
• Score > 2
• 2/3 identification replication
SWATH
MS/MS
Library IDA
MS/MS
XIC – SWATH
MS/MS
SWATH Data File Processing in PeakView® SWATH™ microapp
Note: Protein selected is HCP ID 83
HCP Process Clearance Monitoring
Data Processing and Library Searching – Acceptance Criteria
13
83541324
TOF MS of
sample S3
indicating the
retention times of
identified HCP ID
83, 324, and 541.
S3 S4 S5 S6
HCP 83
HCP 324
HCP 541
XICs of
identified
HCPs
Note: XICs are generated from the sum of the top four transitions per peptide.
HCP Process Clearance Monitoring
Sample Analysis
14
Library ID S3 S4 S5 S6
48 100.00 4.67 2.74 ND
58 100.00 37.61 4.98 ND
83 100.00 1.26 0.19 ND
301 100.00 3.77 6.03 ND
324 100.00 3.83 0.64 0.76
541 100.00 32.97 30.47 31.28
672 100.00 6.83 3.36 ND
HCP Process Clearance Monitoring
HCP Clearance in Percentage-Step 3 through Step 6
HCPs present in S5 shown
17
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
S3 S4 S5 S6
%
Timepoint
HCP's Clearance in Percentage
48 58 83 301 324 541 672
Library ID S3 S4 S5 S6
48 5.74E+05 2.68E+04 1.58E+04 ND
58 6.25E+05 2.35E+05 3.11E+04 ND
83 1.27E+07 1.64E+06 2.38E+04 ND
301 3.81E+05 1.43E+04 2.30E+04 ND
324 2.17E+06 8.28E+04 1.38E+04 1.65E+04
541 1.87E+05 6.16E+04 5.70E+04 5.85E+04
672 3.18E+05 2.17E+04 1.07E+04 ND
HCP Process Clearance Monitoring
HCP Clearance in Area-Step 3 through Step 6
HCPs present in S5 shown
18
1.00E+04
1.00E+05
1.00E+06
1.00E+07
S3 S4 S5 S6
ProteinArea
Timepoint
Log Plot of HCP's Clearance in Area
48 58 83 301 324 541 672
HCP- Quantitation
Proof of Concept – Determining Performance Expectation
Six digested proteins were spiked into a mAb digest.
Dilutions were carried out maintaining [mAb].
*MS Qual/Quant QC Mix from Sigma-Aldrich P/N MSQC1
20
Values are ppm, 30 µg of mAb was loaded on column
11.6 ppm 2.32 ppm
HCP- Quantitation
Proof of Concept: Carbonic Anhydrase I, VLDALQAIK
0.464 ppm 0.0928 ppm
21
62 ppm 12.4 ppm
HCP- Quantitation
Proof of Concept: NAD(P)H dehydrogenase, EGHLSPDIVAEQK
2.48 ppm 0.496 ppm
22
46 ppm 9.2 ppm
HCP- Quantitation
Proof of Concept: C-reactive Protein, ESDTSYVSLK
1.84 ppm 0.368 ppm
23
24 ppm 4.8 ppm
HCP- Quantitation
Proof of Concept: Catalase, NLSVEDAAR
0.96 ppm 0.192 ppm
25
HCP- Quantitation
Proof of Concept - Determining Performance Expectation
Range established to sub ppm levels
Green = Confirmed; Red = Not Confirmed
Values are ppm, 30 µg of mAb was loaded on column
26
• CHO Database in place containing 4 CHO cell lines
• 3802 Proteins
• Generation of new HCP databases within ~2-3 months
• Identifications of HCPs for process monitoring can be
made < 1 ppm, and in some cases <100 ppb
•
• Thank you SCIEX for your support!
HCP– Analysis by Mass Spectrometry
SUMMARY
27

More Related Content

What's hot

Modern pharmaceutical analytical technique ( Electrophoresis)
Modern pharmaceutical analytical technique ( Electrophoresis)Modern pharmaceutical analytical technique ( Electrophoresis)
Modern pharmaceutical analytical technique ( Electrophoresis)
KhushbooKunkulol
 

What's hot (20)

Bacterial Endotoxin Test
Bacterial Endotoxin TestBacterial Endotoxin Test
Bacterial Endotoxin Test
 
Determination of protein concentration by Bradford method.pptx
Determination of protein concentration by Bradford method.pptxDetermination of protein concentration by Bradford method.pptx
Determination of protein concentration by Bradford method.pptx
 
Virtual sreening
Virtual sreeningVirtual sreening
Virtual sreening
 
Capillary electrophoresis final ppt.
Capillary electrophoresis final ppt.Capillary electrophoresis final ppt.
Capillary electrophoresis final ppt.
 
Drug likeness Properties
Drug likeness  PropertiesDrug likeness  Properties
Drug likeness Properties
 
The Many Roles of Computation in Drug Discovery
The Many Roles of Computation in Drug DiscoveryThe Many Roles of Computation in Drug Discovery
The Many Roles of Computation in Drug Discovery
 
Endotoxin testing
Endotoxin testing Endotoxin testing
Endotoxin testing
 
Derivative spectroscopy
Derivative spectroscopyDerivative spectroscopy
Derivative spectroscopy
 
PRINCIPLE , INSTRUMENTATION & APPLICATION OF SUPER CRITICAL FLUID CHROMATOGRAPHY
PRINCIPLE , INSTRUMENTATION & APPLICATION OF SUPER CRITICAL FLUID CHROMATOGRAPHYPRINCIPLE , INSTRUMENTATION & APPLICATION OF SUPER CRITICAL FLUID CHROMATOGRAPHY
PRINCIPLE , INSTRUMENTATION & APPLICATION OF SUPER CRITICAL FLUID CHROMATOGRAPHY
 
Modern pharmaceutical analytical technique ( Electrophoresis)
Modern pharmaceutical analytical technique ( Electrophoresis)Modern pharmaceutical analytical technique ( Electrophoresis)
Modern pharmaceutical analytical technique ( Electrophoresis)
 
Capillary electrophoresis
Capillary electrophoresisCapillary electrophoresis
Capillary electrophoresis
 
LC-MS INSTURMENTATION & APPLICATIONS
LC-MS INSTURMENTATION & APPLICATIONSLC-MS INSTURMENTATION & APPLICATIONS
LC-MS INSTURMENTATION & APPLICATIONS
 
Reverse phase chromatography
Reverse phase chromatographyReverse phase chromatography
Reverse phase chromatography
 
Immunoassay
ImmunoassayImmunoassay
Immunoassay
 
Lipinski rule
Lipinski rule Lipinski rule
Lipinski rule
 
Radio Immuno Assay
Radio Immuno Assay Radio Immuno Assay
Radio Immuno Assay
 
Proteomics Practical (NMR and Protein 3D software
Proteomics Practical (NMR and Protein 3D softwareProteomics Practical (NMR and Protein 3D software
Proteomics Practical (NMR and Protein 3D software
 
Lecture 8 drug targets and target identification
Lecture 8 drug targets and target identificationLecture 8 drug targets and target identification
Lecture 8 drug targets and target identification
 
Biomarker Discovery and Validation
Biomarker Discovery and ValidationBiomarker Discovery and Validation
Biomarker Discovery and Validation
 
Green chromatography
Green chromatographyGreen chromatography
Green chromatography
 

Similar to Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma

Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsBreaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Merck Life Sciences
 
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsBreaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
MilliporeSigma
 
Enhanced bioseparations peptide mapping and m abs
Enhanced bioseparations peptide mapping and m absEnhanced bioseparations peptide mapping and m abs
Enhanced bioseparations peptide mapping and m abs
Oskari Aro
 
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Kate?ina Svobodov
 
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...
AliElmehdawi2
 
High throughput screening (hts) copy
High throughput screening (hts)   copyHigh throughput screening (hts)   copy
High throughput screening (hts) copy
Iqrar Ansari
 
Lecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology blsLecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology bls
Bruno Mmassy
 

Similar to Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma (20)

Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsBreaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
 
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell ProteinsBreaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
Breaking the Status Quo: Using Mass Spectrometry to detect Host Cell Proteins
 
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-en
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-enPp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-en
Pp 90505-lc-ms-serum-profiling-biomarker-msacleu2019-pp90505-en
 
High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...
 
Enhanced bioseparations peptide mapping and m abs
Enhanced bioseparations peptide mapping and m absEnhanced bioseparations peptide mapping and m abs
Enhanced bioseparations peptide mapping and m abs
 
High Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant LibraryHigh Throughput Purification and Characterization of a Protein Variant Library
High Throughput Purification and Characterization of a Protein Variant Library
 
Quantitative Analysis of Transporter Protein using TripleTOF® 6600 System
Quantitative Analysis of Transporter Protein using TripleTOF® 6600 SystemQuantitative Analysis of Transporter Protein using TripleTOF® 6600 System
Quantitative Analysis of Transporter Protein using TripleTOF® 6600 System
 
Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...
Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...
Discovery PBPK: Efficiently using machine learning & PBPK modeling to drive l...
 
Anaquant 20160701
Anaquant 20160701Anaquant 20160701
Anaquant 20160701
 
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...Multi-residue pesticide analysis of food samples using acetonitrile extractio...
Multi-residue pesticide analysis of food samples using acetonitrile extractio...
 
Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
 Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p... Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
Robert T. Dunn, II, Ph.D., DABT, SLAS ADMET Special Interest Group Meeting p...
 
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & PossibilitiesHIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
 
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...
Seth Rodgers - High Throughput Cell Culture Platform for Bioprocess Optimizat...
 
Bioanalytical method development and validation .
Bioanalytical method development and validation .Bioanalytical method development and validation .
Bioanalytical method development and validation .
 
High throughput screening (hts) copy
High throughput screening (hts)   copyHigh throughput screening (hts)   copy
High throughput screening (hts) copy
 
GEN Reprint_LC1536
GEN Reprint_LC1536GEN Reprint_LC1536
GEN Reprint_LC1536
 
Pcrarray
PcrarrayPcrarray
Pcrarray
 
Lecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology blsLecture 2 diagnostic molecular microbiology bls
Lecture 2 diagnostic molecular microbiology bls
 
BILS 2015 Christoph Herwig
BILS 2015 Christoph HerwigBILS 2015 Christoph Herwig
BILS 2015 Christoph Herwig
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization
 

More from KBI Biopharma

Calorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturationCalorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturation
KBI Biopharma
 
Effects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal UnfoldingEffects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal Unfolding
KBI Biopharma
 
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
KBI Biopharma
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
KBI Biopharma
 
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
KBI Biopharma
 

More from KBI Biopharma (20)

Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
 
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
 
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
 
Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...
 
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsPrimary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
 
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
 
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
 
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
 
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
 
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesOctet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation Strategies
 
Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...
 
Calorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturationCalorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturation
 
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
 
Effects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal UnfoldingEffects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal Unfolding
 
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
 
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
 
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
Some Biophysical Methods for Demonstrating Comparability of Conformation and ...
 
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
Limitations and Advantages in Assessing Adenovirus Homogeneity by Laser Light...
 
Characterizing the aggregation and conformation of protein therapeutics
Characterizing the aggregation and conformation of protein therapeuticsCharacterizing the aggregation and conformation of protein therapeutics
Characterizing the aggregation and conformation of protein therapeutics
 

Recently uploaded

Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
Silpa
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.
Silpa
 
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptxTHE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
ANSARKHAN96
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.
Silpa
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Sérgio Sacani
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
NazaninKarimi6
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.
Silpa
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
Scintica Instrumentation
 
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Sérgio Sacani
 
biology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGYbiology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGY
1301aanya
 

Recently uploaded (20)

FAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceFAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical Science
 
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICEPATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.
 
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptxTHE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
 
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and SpectrometryFAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
 
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIACURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
CURRENT SCENARIO OF POULTRY PRODUCTION IN INDIA
 
Thyroid Physiology_Dr.E. Muralinath_ Associate Professor
Thyroid Physiology_Dr.E. Muralinath_ Associate ProfessorThyroid Physiology_Dr.E. Muralinath_ Associate Professor
Thyroid Physiology_Dr.E. Muralinath_ Associate Professor
 
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort ServiceCall Girls Ahmedabad +917728919243 call me Independent Escort Service
Call Girls Ahmedabad +917728919243 call me Independent Escort Service
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.
 
Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
 
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
 
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS ESCORT SERVICE In Bhiwan...
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS  ESCORT SERVICE In Bhiwan...Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS  ESCORT SERVICE In Bhiwan...
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS ESCORT SERVICE In Bhiwan...
 
Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.
 
biology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGYbiology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGY
 
Genetics and epigenetics of ADHD and comorbid conditions
Genetics and epigenetics of ADHD and comorbid conditionsGenetics and epigenetics of ADHD and comorbid conditions
Genetics and epigenetics of ADHD and comorbid conditions
 

Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma

  • 1. a customer and science-focused contract development & manufacturing organization HOST CELL PROTEIN ANALYSIS BY MASS SPECTROMETRY Michael J Nold, Ph.D. Director, Mass Spectrometry Core Facility
  • 2. • Challenges with HCPs • HCP Spectral Library Generation • Process Clearance Monitoring HCP– Analysis by Mass Spectrometry Overview 2
  • 3. HCP– Analysis by Mass Spectrometry Challenges with HCPs • HCPs are impurities generated when recombinant proteins are manufactured. Recombinant proteins are frequently expressed in host cells from various cell lines. • Mammalian, Microbial, Bacterial, Yeast, Plant, Insect • Residual HCPs may affect product quality, safety and efficacy. • Toxicity, immune response to target, adjuvant effect, augment ADA response, bioactivity, product stability, product potency • Risks from a variety of factors • Dosing and dose frequency, patient demographics, route of administration
  • 4. HCP– Analysis by Mass Spectrometry Challenges with HCPs Many Challenges: • Variability of host cell substrates • Large number of protein analytes • Variability of protein population during upstream processing • Parental cell line, cell age, cell viability, feeding strategy, etc. • Dynamic range difference between DP and HCPs ( ≥e6 ) • Detection of HCPs that are not immunogenic à Immunoassay may miss these • HCP population can change during process development • HCPs may copurify with DP – “Hitchhiker” effect
  • 5. HCP– Analysis by Mass Spectrometry Challenges with HCPs Mass Spectrometry Challenges: • Column capacity, sample loading • DP overload on column • Mass spectrometer sensitivity • Dynamic range for ion detections • False positives, negatives • Ion statistics for identification, quantitation • Speed – Data to results to support process development • Does library reflect the process? • Time to generate a new library
  • 6. KBI HCP Reagents and Applications PHYSICAL CHEMICAL ATTRIBUTE #1 PHYSICAL CHEMICAL ATTRIBUTE #3 PHYSICAL CHEMICAL ATTRIBUTE #2 6
  • 7. HCP– MS Workflow Overview LCMS via ACQUITY/6600 TripleTOF Spectral Library Generation Sample Analysis Data Processing and Library Searching Data Independent Acquisition SWATH MS Data Dependent Acquisition LC-MS/MS CHO HCCF Various Separation Methodologies Protein Level Additional Separation/ Digest Peptide Level Spectral Library 1% FDR Various Separation Methodologies Protein Level Additional Separation/ Digest Peptide Level List of identified proteins and peptides Spectral library matching based on set search criteria and thresholds Sample 7
  • 8. HCP– MS Workflow Overview LCMS via ACQUITY/6600 TripleTOF Spectral Library Generation Sample Analysis Data Processing and Library Searching Data Independent Acquisition SWATH MS Data Dependent Acquisition LC-MS/MS CHO HCCF Various Separation Methodologies Protein Level Additional Separation/ Digest Peptide Level Spectral Library 1% FDR Various Separation Methodologies Protein Level Additional Separation/ Digest Peptide Level List of identified proteins and peptides Spectral library matching based on set search criteria and thresholds Sample 7
  • 9. HCP Spectral Library Generation Sample Preparation on the Protein and Peptide Level Process Samples 1D Analysis - No peptide level fractionation Process Samples 2D Analysis - High pH RP-HPLC peptide level fractionation Fraction 3 Fraction 2 Fraction 1 Fraction 4 Fraction 5 Peptide level fractionation of 5 of the 8 protein fractionated samples PHYSICAL CHEMICAL ATTRIBUTE #1 PHYSICAL CHEMICAL ATTRIBUTE #3 PHYSICAL CHEMICAL ATTRIBUTE #2 8
  • 10. HCP Spectral Library Generation Sample Load Optimization • Load Optimization Goal: achieve a dynamic range of ≥ 3 logs at the protein level for each experiment. • Utilize the ITC (ion transmission control) Count Conversion of the TOF MS TIC to determine the appropriate amount on column: optimized load when the TOF MS TIC apex is between 10-20%. • ITC: dynamically adjusts percent of the ion beam (voltage gate) according to an observed TIC signal to prevent saturation. • ITC Count Conversion plots the ITC voltage gate response: no signal / gate fully open = 100% saturation / gate fully closed = 0% TOF MS TIC – SWATH ITC Count Conversion of the TOF MS TIC – SWATH TOF MS TIC Apex 9
  • 11. 1.E+04 1.E+06 1.E+08 0 10 20 30 40 50 ProteinArea Protein Number Log Plot of Protein Dynamic Range HCP Spectral Library Generation Sample Load Optimization – Depth of Database • ADH: spiked in all samples at 300 fmol/µL**, used as a system suitability test and the signal response for relative quantitation. • PCM: spiked in all samples at 100 fmol/µL**, used as a retention time calibrator allowing for retention time alignment on any chromatographic system or timescale. ** Concentration of ADH and PCM is relative to 2 µg/µL of total HCP concentration. XIC - Yeast Alcohol Dehydrogenase (ADH) XIC - Peptide Calibration Mix (PCM) Graph generated using the HCPs identified in sample S3 to conceptually show the dynamic range of identified HCPs. 10
  • 12. HCP Spectral Library Generation IDA Library Data Collection and Processing ProteinPilot™ data processing w/ Paragon™ Algorithm. IDA spectral library Filter IDA spectral library based on acceptance criteria. • Acceptance Criteria for Library: • 1% FDR • No modifications or clipped peptides • Minimum of 2 peptide identifications per protein • Peptide Confidence Level: 95% • 10 ppm mass error tolerance • 2/2 identification replication Acquire IDA data in duplicate for each of 28 HCP samples/fractions. 11
  • 13. HCP Spectral Library Generation Contributions from 3 physiochemical preparations & fractionation Physiochemical Attribute 1 1850 Proteins Physiochemical Attribute 2 2925 Proteins Physiochemical Attribute 3 2137 Proteins 3802 Proteins 114 304 1047 598 976 385 378
  • 14. • HCPs are monitored from samples collected along a purification process, either for process development feedback, or monitoring a final process for one or more batches. • Samples are analyzed in triplicate, and identifications will have to meet a set of criteria at both peptide and protein levels. • Results include the list of identified HCPs, and relative quantitative information. • As an illustration, samples were obtained from the last four points of sampling from one of our programs. Protein A Viral Inactivation AEX* Based Polishing (Flow Through mode) CEX* Based Polishing Viral Filtration UF/DF Clarified Harvest *May be mixed mode S3 S4 S5 S6 HCP Process Clearance Monitoring Stand Alone, ELISA Support, or Process Development Support 7193 ppm 125 ppm 10 ppm 4 ppm 12
  • 15. SWATH data file HCP Ion Library Selected Protein Selected Peptide Acceptance Criteria • 2 Peptides per protein • 4 transitions per peptide • FDR: 1.0% • Peptide Confidence Threshold > 99% • MS/MS ppm: 20.0 ppm • Score > 2 • 2/3 identification replication SWATH MS/MS Library IDA MS/MS XIC – SWATH MS/MS SWATH Data File Processing in PeakView® SWATH™ microapp Note: Protein selected is HCP ID 83 HCP Process Clearance Monitoring Data Processing and Library Searching – Acceptance Criteria 13
  • 16. 83541324 TOF MS of sample S3 indicating the retention times of identified HCP ID 83, 324, and 541. S3 S4 S5 S6 HCP 83 HCP 324 HCP 541 XICs of identified HCPs Note: XICs are generated from the sum of the top four transitions per peptide. HCP Process Clearance Monitoring Sample Analysis 14
  • 17. Library ID S3 S4 S5 S6 48 100.00 4.67 2.74 ND 58 100.00 37.61 4.98 ND 83 100.00 1.26 0.19 ND 301 100.00 3.77 6.03 ND 324 100.00 3.83 0.64 0.76 541 100.00 32.97 30.47 31.28 672 100.00 6.83 3.36 ND HCP Process Clearance Monitoring HCP Clearance in Percentage-Step 3 through Step 6 HCPs present in S5 shown 17 0.00 10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00 S3 S4 S5 S6 % Timepoint HCP's Clearance in Percentage 48 58 83 301 324 541 672
  • 18. Library ID S3 S4 S5 S6 48 5.74E+05 2.68E+04 1.58E+04 ND 58 6.25E+05 2.35E+05 3.11E+04 ND 83 1.27E+07 1.64E+06 2.38E+04 ND 301 3.81E+05 1.43E+04 2.30E+04 ND 324 2.17E+06 8.28E+04 1.38E+04 1.65E+04 541 1.87E+05 6.16E+04 5.70E+04 5.85E+04 672 3.18E+05 2.17E+04 1.07E+04 ND HCP Process Clearance Monitoring HCP Clearance in Area-Step 3 through Step 6 HCPs present in S5 shown 18 1.00E+04 1.00E+05 1.00E+06 1.00E+07 S3 S4 S5 S6 ProteinArea Timepoint Log Plot of HCP's Clearance in Area 48 58 83 301 324 541 672
  • 19. HCP- Quantitation Proof of Concept – Determining Performance Expectation Six digested proteins were spiked into a mAb digest. Dilutions were carried out maintaining [mAb]. *MS Qual/Quant QC Mix from Sigma-Aldrich P/N MSQC1 20 Values are ppm, 30 µg of mAb was loaded on column
  • 20. 11.6 ppm 2.32 ppm HCP- Quantitation Proof of Concept: Carbonic Anhydrase I, VLDALQAIK 0.464 ppm 0.0928 ppm 21
  • 21. 62 ppm 12.4 ppm HCP- Quantitation Proof of Concept: NAD(P)H dehydrogenase, EGHLSPDIVAEQK 2.48 ppm 0.496 ppm 22
  • 22. 46 ppm 9.2 ppm HCP- Quantitation Proof of Concept: C-reactive Protein, ESDTSYVSLK 1.84 ppm 0.368 ppm 23
  • 23. 24 ppm 4.8 ppm HCP- Quantitation Proof of Concept: Catalase, NLSVEDAAR 0.96 ppm 0.192 ppm 25
  • 24. HCP- Quantitation Proof of Concept - Determining Performance Expectation Range established to sub ppm levels Green = Confirmed; Red = Not Confirmed Values are ppm, 30 µg of mAb was loaded on column 26
  • 25. • CHO Database in place containing 4 CHO cell lines • 3802 Proteins • Generation of new HCP databases within ~2-3 months • Identifications of HCPs for process monitoring can be made < 1 ppm, and in some cases <100 ppb • • Thank you SCIEX for your support! HCP– Analysis by Mass Spectrometry SUMMARY 27